Home page  |  About this library  |  Help  |  Clear       English  |  French  |  Spanish  
Expand Document
Expand Chapter
Full TOC
Preferences
to next section

close this bookEssential Medicines: WHO Model List (Revised March 2005) - Explanatory Notes (WHO; 2005; 24 pages) View the PDF document
View the document1. ANAESTHETICS
View the document2. ANALGESICS, ANTIPYRETICS, NON-STEROIDAL ANTI-INFLAMMATORY MEDICINES (NSAIMs), MEDICINES USED TO TREAT GOUT AND DISEASE MODIFYING AGENTS IN RHEUMATOID DISORDERS (DMARDs)
View the document3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
View the document4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS
View the document5. ANTICONVULSANTS/ANTIEPILEPTICS
View the document6. ANTI-INFECTIVE MEDICINES
View the document7. ANTIMIGRAINE MEDICINES
View the document8. ANTINEOPLASTIC, IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE
View the document9. ANTIPARKINSONISM MEDICINES
View the document10. MEDICINES AFFECTING THE BLOOD
View the document11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES
View the document12. CARDIOVASCULAR MEDICINES
View the document13. DERMATOLOGICAL MEDICINES (topical)
View the document14. DIAGNOSTIC AGENTS
View the document15. DISINFECTANTS AND ANTISEPTICS
View the document16. DIURETICS
View the document17. GASTROINTESTINAL MEDICINES
View the document18. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES
View the document19. IMMUNOLOGICALS
View the document20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS
View the document21. OPHTHALMOLOGICAL PREPARATIONS
View the document22. OXYTOCICS AND ANTIOXYTOCICS
View the document23. PERITONEAL DIALYSIS SOLUTION
View the document24. PSYCHOTHERAPEUTIC MEDICINES
View the document25. MEDICINES ACTING ON THE RESPIRATORY TRACT
View the document26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES
View the document27. VITAMINS AND MINERALS
 

Essential Medicines: WHO Model List (Revised March 2005) - Explanatory Notes

14th edition (March 2005)

The core list presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost-effective medicines for priority conditions. Priority conditions are selected on the basis of current and estimated future public health relevance, and potential for safe and cost-effective treatment.

The complementary list presents essential medicines for priority diseases, for which specialized diagnostic or monitoring facilities, and/or specialist medical care, and/or specialist training are needed. In case of doubt medicines may also be listed as complementary on the basis of consistent higher costs or less attractive cost-effectiveness in a variety of settings.

When the strength of a drug is specified in terms of a selected salt or ester, this is mentioned in brackets; when it refers to the active moiety, the name of the salt or ester in brackets is preceded by the word "as".

The square box symbol () is primarily intended to indicate similar clinical performance within a pharmacological class. The listed medicine should be the example of the class for which there is the best evidence for effectiveness and safety. In some cases, this may be the first medicine that is licensed for marketing; in other instances, subsequently licensed compounds may be safer or more effective. Where there is no difference in terms of efficacy and safety data, the listed medicine should be the one that is generally available at the lowest price, based on international drug price information sources. Therapeutic equivalence is only indicated on the basis of reviews of efficacy and safety and when consistent with WHO clinical guidelines. National lists should not use a similar symbol and should be specific in their final selection, which would depend on local availability and price.

Drugs are listed in alphabetical order, within sections.

 

to next section

Please provide your feedback   English  |  French  |  Spanish